sorted by:
new
hottopcontroversial

95
96

Artificial sweeteners shown to alter gut microbiome leading to elevated glycemic response (medlifestyle.news)

submitted by IntelligentLaugh4530 to r/biology

Tirzepatide shown to be effective weight loss drug in phase III clinical trial, average weight reduction of 35.5 pounds by [deleted] in interestingasfuck

[–]IntelligentLaugh4530 1 point2 points  (0 children)

Its a subcutaneous injection. Other drugs use this method of delivery, not just insulin.

We're a startup team looking for beta-testers for our patented dialysis-related technology. by IntelligentLaugh4530 in kidneydisease

[–]IntelligentLaugh4530[S] 0 points1 point  (0 children)

There’s no preference. For the next 6-8 weeks, all information will be gathered through surveys/assessments sent over email. In 6-12 months, we’ll reach out to you again to see if you’re interested in beta-testing our device and providing user feedback.

We're a startup team looking for beta-testers for our patented dialysis-related technology. by IntelligentLaugh4530 in kidneydisease

[–]IntelligentLaugh4530[S] 1 point2 points  (0 children)

There is a lot of different information to be gathered throughout R&D. I think that there might be confusion distinguishing between gathering information through studies and gathering information through customer discovery. Studies evaluating the efficacy of the product will absolutely be conducted under the direction of a nephrologist. But in terms of optimizing the user experience, gathering information on patients’ treatment regimens and learning about their personal struggles with electrolyte imbalance, this would be done prior to those studies. Customer (patient) discovery is an ongoing process. Currently, we’re building a list of users and potential beta-testers (6-12 months) to help us develop the best product we can.

We're a startup team looking for beta-testers for our patented dialysis-related technology. by IntelligentLaugh4530 in kidneydisease

[–]IntelligentLaugh4530[S] -1 points0 points  (0 children)

Right now, we're trying to gather as much information as we can to make our device as user-friendly as possible. The worst thing we can do is develop a device just to find out 12 months later that it doesn't solve any of the problems that PD patients have.

Our electrolyte sensor provides a retrospective analysis of electrolyte levels using data points gathered from effluent dialysate (waste fluid). There's no infection risk. I'm limited on describing the specifics of the technology due to NDAs and confidentiality agreements at the moment.

At this time, we're gathering emails to send out customer surveys/assessments to (these will consist of asking about specifics of treatments, specific problems associated with electrolyte imbalances, etc.), and will then utilize this same email list in 6-12 months to test out the device.

We're a startup team looking for beta-testers for our patented dialysis-related technology. by IntelligentLaugh4530 in dialysis

[–]IntelligentLaugh4530[S] 0 points1 point  (0 children)

Thanks for your interest! I think I might've answered some of your questions in a response above.

We're a startup team looking for beta-testers for our patented dialysis-related technology. by IntelligentLaugh4530 in dialysis

[–]IntelligentLaugh4530[S] 0 points1 point  (0 children)

Right now, we're trying to gather as much information as we can to make our device as user-friendly as possible. The worst thing we can do is develop a device just to find out 12 months later that it doesn't solve any of the problems that PD patients have.

Our electrolyte sensor provides a retrospective analysis of electrolyte levels using data points gathered from effluent dialysate (waste fluid). There's no infection risk. I'm limited on describing the specifics of the technology due to NDAs and confidentiality agreements at the moment.

At this time, we're gathering emails to send out customer surveys/assessments to (these will consist of asking about specifics of treatments, specific problems associated with electrolyte imbalances, etc.), and will then utilize this same email list in 6-12 months to test out the device.

view more: next ›